Sucampo Announces Departure of CFO

Sucampo Pharmaceuticals, Inc. (Sucampo)

, a global biopharmaceutical company, today announced that Cary J. Claiborne, Chief Financial Officer (CFO), is leaving Sucampo to pursue other interests. Mr. Claiborne will continue in his current role through November 7, 2014, and Sucampo has initiated a search for a new CFO. "The Board and I would like to thank Cary for the contributions he has made to Sucampo during his tenure as CFO, and we wish him the very best in his future endeavors," said Peter Greenleaf, Chief Executive Officer of Sucampo. "Our focus today is solidly on executing the strategy we have defined to drive the next evolution of Sucampo and on accomplishing the ambitious goals we have set for ourselves to drive increased shareholder and patient value: strengthening our organizational capabilities and leadership team, securing our revenue from AMITIZA in the U.S. and globally, focusing our scientific investments to accelerate our pipeline, and diversifying our science."